Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
September 29, 2008
New field of metabolomics yields exciting antiviral treatment approach
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.
Metabolism refers to all the reactions by which living things break down nutrients to produce energy, along with those by which they rebuild broken-down nutrients into complex molecules (e.g. DNA). A significant example is the breakdown of blood sugar (e.g. glucose) and its conversation via chain reactions into adenosine triphosphate, the energy-storing currency of cellular life. As an important offshoot of that process, glucose can also be converted into fatty acids, the lipid building blocks of human hormones and cell membranes. Many viruses, including influenza, HIV and hepatitis, use those same fatty acids to build instead their viral envelopes, outer coatings that help them penetrate human cells. Going into the study, little was known about the mechanisms through which viruses hijack metabolic building blocks from their cellular hosts, with older techniques providing a limited picture.
In the current study, a team of researchers from the University of Rochester Medical Center and Princeton University created a new technique to clarify these mechanisms, and found that the technique could identify anti-viral therapeutic targets. Researchers combined drug discovery technologies to capture for the first time the exact concentrations and turnover, in other words, the fluxes, of interchangeable molecules within the metabolic chain reactions that convert sugars into fatty acids. The fields of metabolomics and fluxomics have emerged to measure these patterns, and to provide insight into diseases with a metabolic component, from diabetes to infectious diseases to cancer.
"Using new fluxomic techniques, our study reveals that viral infection takes control of cellular metabolism and drives, among other things, marked increases in fatty acid synthesis," said Joshua Munger, Ph.D., assistant professor of Biochemistry and Biophysics at the University of Rochester Medical Center, and a study author. "We also found that if you target these increases in fatty acid metabolism using existing anti-obesity and anti-metabolism drugs, you inhibit viral replication."
A Thousand-fold Reduction in Viral Replication
In their experiments, Munger and colleagues developed a technique to measure changes in metabolic flux in human cells as they become infected by human cytomegalovirus (HCMV), an enveloped virus of the b-herpes family that infects most human adults and that causes severe disease in those with weakened immune systems. Researchers chose cytomegalovirus for experiments because it serves as an excellent model for processes at play in many enveloped viral infections and in cancers. HCMV replicates in a variety of human cell types, including fibroblasts, the cell type used in the study.
To study metabolic flux, Munger and his team created a stable, isotope-labeled version of glucose, which when "fed" to cells, was metabolized in a similar fashion as unlabeled glucose. Liquid chromatography and mass spectrometry were then employed to track the isotope label as it spread, or permeated, through the metabolic network. The impact of viral infection on cellular metabolism could be measured by the speed at which the labeled version spread, and then compared to uninfected cells. Given the complexity of interconnections within the metabolic network, the team also developed a novel computer model of metabolic function to analyze the data and guide further experimentation.
Many metabolic processes are essential to the survival of human cells, and so are not candidates for research efforts that would shut them down in the attempt to stop viral replication. For that reason, Munger and colleagues chose to look at whether interfering with glucose-to-fatty acid metabolism could stop viral replication, because fatty acid biosynthesis is not essential in adult humans. It does appear, however, to be essential to the ability of viruses to build their envelopes, reproduce and spread.
Thus, the team next used drugs known to inhibit enzymes that build fatty acids, acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS), used in the treatment of obesity and high cholesterol, to determine whether HCMV-induced fatty acid production was necessary for enveloped viruses to make copies of themselves. Indeed, treatment (10 mg ml-1) with 5-tetradecyloxy-2-furoic acid (TOFA), an ACC inhibitor, resulted in a more than thousand-fold reduction in HCMV replication. C75 (trans-4-carboxy-5-octyl-3-methylene-butyrolactone), an inhibitor of FAS, resulted in a more than 100-fold effect at the same dose.
To investigate whether this requirement extended to other enveloped viruses, the team measured influenza A replication in the presence of the same TOFA and FAS inhibitors, and found similar reductions in replication. Influenza A has little in common with HCMV except for its lipid envelope.
Extensive clinical testing would be needed to draw conclusions about the safety of TOFA and C75, or similar compounds, as antiviral treatment. That said, the team took an early look at toxicity, exposing uninfected fibroblasts to C75 or TOFA for 96 hours. They found that the drugs blocked HCMV replication without causing cell toxicity or self-destruction (apoptosis).
Along with Munger, Jessica McArdle of the Department of Biochemistry and Biophysics contributed to the work. Bryson Bennett also worked on the project from the Lewis-Sigler Institute for Integrative Genomics in the Carl Icahn Laboratory at Princeton University. Leading the effort from the Princeton side was the corresponding author, Joshua Rabinowitz, who worked with Anuraag Parikh, Thomas Shenk in the Department of Molecular Biology, and Xiao-Jiang Feng and Herschel Rabitz at the Frick Laboratory. The work was supported by the National Institutes of Health (NIH) Metabolomics Roadmap initiative, the National Science Foundation, the Beckman Foundation, the American Heart Association, the National Science Foundation and the American Cancer Society.
"Recent studies have shown that fatty acid biosynthesis is important for the replication of diverse enveloped viruses," Munger said. "The replication of both hepatitis C and HIV, for example, has been linked recently with lipid synthesis, reinforcing our approach and its importance. Lastly, viral infection also clearly upregulates glycolysis, a marker for tumor growth, which is just the latest in the longstanding connection between viruses and cancer. Hopefully, our work will at some point provide insight into the metabolic manipulations seen in cancer as well."
University of Rochester Medical Center

|
Fatty Acids: Types, Roles and Health Effects (Biochemistry Research Trends: Nutrition and Diet Research Progress)
by Grace Chen (Editor)
In this book, the authors present topical research from across the globe in the study of the types, roles and health effects of fatty acids. Topics discussed include the chemical structure and classification of fatty acids; n-3 polyunsaturated fatty acids in brain resistance to ageing; the role of dietary fatty acids for developmental and disease states in domestic animals; and, the effects of fatty acid synthase on fatty acids biogenesis in metabolic syndrome and lipotoxicity on human pancreatic beta-cells.
|

|
Dispelling the Myths About Omega-3 Fatty Acids (Postgraduate Medicine)
by JTE Multimedia
Abstract: Although there is an enormous amount of information available on omega-3 fatty acids, it is sometimes misleading, contradictory, and unsupported by scientific fact. Consumers and medical professionals may be confused regarding the potential value of omega-3 fatty acid supplements, despite having either read or heard about fish oil consumption and/or omega-3 fatty acid benefits and risks. The availability of a prescription formulation of omega-3-acid ethyl esters (P-OM3) has provided important new information that helps to dispel the myths and alleviate concerns surrounding the use of omega-3 fatty acids in clinical practice. The safety and efficacy of P-OM3, but not dietary-supplement omega-3 fatty acids, are documented in placebo-controlled trials. In general, studies using...
|
|
|
Essential Fatty Acids and Eicosanoids: Invited Papers from the Third International Congress
by S. Aust.) International Congress on Essential Fatty Acids and Eicosanoids (3rd : 1992 : Adelaide (Author), Andrew Sinclair (Author), Robert Gibson (Author), Robert Gibson (Editor), American Oil Chemists' Society (Editor)
|

|
The Mystery Of Fatty Acids Revealed
Much has been written about essential fatty acids. Yes many people still don’t have a full grasp of how these fatty acids function in their bodies. They don’t have the slightest idea of the chemical pathways these fatty acids take before they become the prostaglandin substances that provide them with the advertise benefits.
If you’re tired of being in the dark about how your body processes fatty acids or the omegas, then you are in for a treat. This e-book gives you simple high powered explanations of how the omegas change to become EPA, DHA, AA, GLA, DPA, or prostaglandins.
You will find the true omega 3 benefits. You will discover how to make sure you enhance the level of the prostaglandin that gives your body the health you deserve.
Go ahead buy...
|

|
Understanding Fats & Oils: Your Guide to Healing With Essential Fatty Acids
by Michael T. Murray (Author), Jade Beutler (Author)
At last, a brief yet comprehensive review of the vital role of fats and oils in the diet. In "Understanding Fats and Oils" you will learn of the phenomenal healing powers of a specialized class of nutrients identified as essential fatty acids - and much more! Including: Which fats are bad and which are good; Why flaxseed oil is the best for human health; Dietary recommendations; Balancing fats in our diet for optimal health; Recognizing a deficiency of essential fatty acids; Dangers of hydrogenated and trans fatty acids; Lowering cholesterol and blood pressure with essential fatty acids.
|
|
|
Omega 3 fatty acids.(NUTRACEUTICALS RESEARCH): An article from: Nutraceuticals World
by Gale Reference Team (Author)
This digital document is an article from Nutraceuticals World, published by Rodman Publishing on November 1, 2007. The length of the article is 345 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details Title: Omega 3 fatty acids.(NUTRACEUTICALS RESEARCH) Author: Gale Reference Team Publication: Nutraceuticals World (Magazine/Journal) Date: November 1, 2007 Publisher: Rodman Publishing Volume: 10 Issue: 10 Page: 56(1)
Distributed by Gale, a part of Cengage...
|

|
Effect of Fish Oil-Derived Omega-3 Polyunsaturated Fatty Acid Supplementation on Exercise-Induced Bronchoconstriction and Immune Function in Athletes (The Physician and Sportsmedicine)
by JTE Multimedia
Abstract: Exercise-induced bronchoconstriction (EIB) is a condition in which vigorous physical activity triggers acute airway obstruction in asthmatic and nonasthmatic individuals with hyperresponsive airways. Studies have shown that inflammatory mediators and contraction of airway smooth muscle are central components in the pathogenesis of EIB, and it has long been recognized that leukotrienes and prostaglandins play an important role in the EIB response. Clinical responses to current therapy, such as leukotriene modifiers and corticosteroids are heterogeneous, and even with optimal treatment there is a substantial burden of unaddressed disease. While daily medications such as leukotriene modifiers provide only modest protection against symptoms, prolonged use of several medications can...
|

|
Fatty acid metabolism and its regulation, Volume 7 (New Comprehensive Biochemistry)
by Author Unknown (Editor)
|

|
Healthy Fats for Life: Preventing and Treating Common Health Problems with Essential Fatty Acids
by Lorna R. Vanderhaeghe (Author), Karlene Karst (Author)
You CAN eat fat and be healthy!For years we have been told that "fat" is bad for us. But the low-fat and no-fat-diets designed to improve our health have instead created an overweight society with skyrocketing rates of heart disease and diabetes. Recent scientific research has shown that certain types of essential fatty acids (EFAs) — healthy fats — improve immune and hormone functions, and play a vital role in treating all forms of degenerative disease, including cancer.Healthy Fats for Life will help you to understand the difference between "good" fats and "bad" fats, while providing a simple plan for obtaining essential fats to reach optimum health. Learn how to:reduce your weightlower your cholesterolcontrol your diabetesprevent heart diseasereduce the risk of cancerimprove brain...
|

|
Flax! Fabulous Flax: Nature's Best Source of Omega-3 Fatty Acids and Lignan Fiber! (Health Learning Handbook)
by Beth M. Ley (Author)
Flax seeds are nature’s best source of not one, but TWO essential dietary components most people are lacking due to diets high in refined foods: Omega-3 fatty acids and fiber! Flax seeds contain: Lignans, special fiber compounds protect against cancer, especially of the colon, prostate, breast and reproductive system. Fiber also aids digestive disorders such as constipation and irritable bowel. It is also protective against heart disease and cancer. Phytoestrogens to balance hormone levels and benefit pms, menopause and other hormonal disorders such as acne. Omega-3 essential fatty acids to aid in weight loss, to help inflammatory disorders (arthritis, lupus, psoriasis, etc.), reduce risk of heart disease by lowering elevated cholesterol and triglycerides, reducing blood...
|